A detailed history of Platinum Investment Management LTD transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Platinum Investment Management LTD holds 1,970 shares of CORT stock, worth $177,930. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,970
Previous 2,598 24.17%
Holding current value
$177,930
Previous $296,000 51.35%
% of portfolio
0.01%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 18, 2025

SELL
$62.24 - $91.93 $39,086 - $57,732
-628 Reduced 24.17%
1,970 $144,000
Q1 2025

May 15, 2025

BUY
$49.85 - $114.22 $86,838 - $198,971
1,742 Added 203.5%
2,598 $296,000
Q4 2024

Feb 10, 2025

SELL
$44.66 - $60.85 $16,747 - $22,818
-375 Reduced 30.46%
856 $43,000
Q3 2024

Nov 07, 2024

BUY
$29.51 - $46.26 $36,326 - $56,946
1,231 New
1,231 $56,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $9.67B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.